FdaApplication

NDA 202570

Back to search

Identifiers

Properties

PropertyValue
applicant_namePF PRISM CV
application_typeNDA
approval_date2011-08-26

Products (2)

ProductActive ingredientStrengthDosage form
XALKORICRIZOTINIB250MGCAPSULE;ORAL
XALKORICRIZOTINIB200MGCAPSULE;ORAL

2 products